the aid library

LIST OPTIONS

Filter

14957

Sort by:

Direction:

Download (259)

View PDF (391)

Burundi Regional Refugee Response Plan: January - December 2018

United Nations High Commissioner for Refugees (UNHCR) (2017) C1

As the Burundi refugee crisis enters its fourth year, some 430,000 Burundian refugees are being hosted across the region by the governments and people of Tanzania, Rwanda, the Democratic Republic of the Congo, and Uganda. Although the spectre of mass violence in Burundi has receded, with the politic... more

Download (174)

View PDF (310)

Policy Options on Mental Health

World Health Organization WHO Calouste Gulbenkian Foundation (2017) C_WHO

"This is the final report of the six-year collaboration between the WHO Department of Mental Health and Substance Abuse and the Gulbenkian Global Mental Health Platform, an initiative of the Calouste Gulbenkian Foundation aimed at reducing the global burden of mental health through the development a... more

Download (501)

View PDF (3526)

Adolescent HIV Care and Treatment: A Training Curriculum for Health Workers (Zambia) Trainer Manual

ICAP; CDC; University Teaching Hospital,; Ministry of Health, Zambia, et al. (2011) C1

A Training Curriculum for Multidisciplinary Healthcare Teams. This innovative training package aims to empower multidisciplinary health workers to have the confidence and skills to provide comprehensive, youth-friendly HIV services that support adolescents’ healthy development, psychosocial well b... more

Download (185)

View PDF (255)

Global Health Risks

World Health Organization WHO (2009) C_WHO

Mortality and burden of disease attributable to selected major risks

Download (640)

View PDF (820)

Medikamente in Deutschland - Informationen für Migranten

ABDA Bundesvereinigung Deutscher Apothekerverbände (2016) CC

Informationen für Migranten. Wie funktionieren deutsche Apotheken und wie bekommen Patienten Medikamente? Was ist der Unterschied zwischen verschreibungspflichtigen und apothekenpflichtigen Arzneimitteln? Was kosten Medikamente? Zu diesen und weiteren grundlegenden Fragen hat die ABDA – Bundesver... more

Download (875)

View PDF (1195)

How effective are community health workers?

Henry Perry; Rose Zulliger John Hopkins Bloomberg University (2012)

An Overview of Current Evidence with Recommendations for Strengthening Community Health Worker Programs to Accelerate Progress in Achieving the Health-related Millennium Development Goals

Download (98)

View PDF (109)

A handbook on mainstreaming disability

D. Jones and Li Webster VSO UK; VSO Indonesia; Cordaid (2006) CC

This handbook aims to give practical guidance to support development organisations to mainstream disability into their work. It is primarily intended for VSO programmes, but could be useful to other development actors interested in mainstreaming disability, such as NGOs, gover... more

Download (429)

View PDF (545)

Contingency Plan. Nepal: Earthquake

Humanitarian Country Team (HCT), Nepal (2016) C1

In April and May 2015, Nepal was hit by two major earthquakes killing around 9,000 people and leaving many thousands more injured and homeless.
To optimize the speed and volume of critical humanitarian assistance, the HCT has developed this Plan to:
1. Reach a common understanding of earth... more

Download (435)

View PDF (481)

Every child alive: The urgent need to end newborn deaths

UNICEF (2018)

Globally, in low-income countries, the average newborn mortality rate is 27 deaths per 1,000 births, the report says. In high-income countries, that rate is 3 deaths per 1,000. Newborns from the riskiest places to give birth are up to 50 times more likely to die than those from the safest places.... more

Download (818)

View PDF (2473)

IASC operational guidelines on human rights and natural disaster

Brookings-Bern Project on Internal Displacement (2008)

Operational Guidelines and Field Manual on Human Rights Protection in Situations of Natural Disaster

Download (57)

View PDF (85)

Unaccompanied Minors in Germany - Reception, return and integration arrangements

German National Contact Point EMN (2009) CC

The processes and procedures that are applied upon the entry into Germany of unaccompanied minors, do not always follow any one precisely prescribed model that remains consistent throughout Germany. Apart from the asylum procedure and some aspects of border control, the reception of UNAMs is a re... more

Download (55)

View PDF (81)

Investing in and building longer-term health emergency preparedness during the COVID-19 pandemic
recommended

World Health Organization WHO (2020) C_WHO

Interim Guidance This document is to help Member States build on actions taken during the COVID-19 pandemic to improve national medium- to long-term preparedness for future threats. It maps COVID-19 preparedness and response actions to the building of sustainable International Health Regulations (2... more

Download (63)

View PDF (90)

Das Geschäft mit der Not - Menschenhandel von geflüchteten Kindern und Heranwachsenden in Deutschland

terre des hommes, ECPAT (2018) CC

Die Zahl der unbegleiteten und von ihren Eltern getrennten Kinder in Migration und auf der Flucht nimmt auf der Balkanroute ständig zu. Diese Kinder sind in höchstem Masse gefährdet, Opfer von Kinderhandel und Ausbeutung zu werden. terre des hommes und ECPAT Deutschland e. V. haben ihre Lage in D... more

Download (87)

View PDF (151)

Hinweise zu Prävention und Management von COVID-19-Erkrankungen in Gemeinschaftsunterkünften für Geflüchtete

Robert-Koch-Institut RKI (2020) CC

Das Übertragungsrisiko virusbedingter Erkrankungen der Atemwege ist in Gemeinschaftsunterkünften(darunter sind im Folgenden alle Sammelunterbringungen für Geflüchtete und Asylsuchende gemäss IfSG gemeint, inkl. Erstaufnahmeeinrichtungen/ANKER Einrichtungen sowie alle Anschlussunterbringungen) b... more

Download (104)

View PDF (127)

COVID-19: Guidelines for communicating about coronavirus disease 2019 - A guide for leaders

Pan American Health Organisation PAHO (2020) C_WHO

Risk communication encompasses all the basics of health communication but differs in the need for speed and reliance on trust. At times of crisis, leaders are called on to provide a quick, sensitive and trustworthy response.

Download (75)

View PDF (84)

Practical guide to inclusive and rights-based responses to Covid-19 in the Americas

OAS (2020) CC

WHY THIS GUIDE? Because, in the face of crises and emergencies, it is vital to include a human rights perspective in responses. Vulnerable groups face major obstacles to accessing and benefiting from prevention, mitigation, and health care policies due to structural barriers of inequality. To offer... more

Download (41)

View PDF (238)

Una Nueva Esperanza Para Pacientes Con Leishmaniasis

Drugs for Neglected Diseases initiative DNDi (2022) CC

La leishmaniasis es una enfermedad tropical desatendida sensible al clima, trasmitida por la picadura de insectos flebótomos y se calcula que amenaza a mil millones de personas en todo el mundo. Esta enfermedad altamente compleja se presenta de varias formas clínicas, causadas por 20 especies ... more

Download (124)

View PDF (121)

Infection prevention and control in the context of coronavirus disease (‎COVID-19)‎: a living guideline, 13 January 2023

World Health Organisation (WHO) (2023) C_WHO

The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171 countries across all six WHO Regions and was rapidly re... more

Download (115)

View PDF (122)

WHO presence in countries, territories and areas: 2023 report

World Health Organisation (WHO) (2023) C_WHO

The 2023 Country Presence Report provides an overview of what WHO does in countries to advance towards the SDGs and implement GPW13, how we do it, with whom we work, and what is needed to overcome challenges for achieving results and impact in countries.

Download (176)

View PDF (247)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Investing in and building longer-term health emergency preparedness during the COVID-19 pandemic recommended

Investing in and building longer-term health emergency preparedness during the COVID-19 pandemic
recommended